000141870 001__ 141870
000141870 005__ 20240229105134.0
000141870 0247_ $$2doi$$a10.1002/ijc.31628
000141870 0247_ $$2pmid$$apmid:29923613
000141870 0247_ $$2ISSN$$a0020-7136
000141870 0247_ $$2ISSN$$a1097-0215
000141870 037__ $$aDKFZ-2018-02127
000141870 041__ $$aeng
000141870 082__ $$a610
000141870 1001_ $$0P:(DE-He78)448ff49e51672d79b4747339ac15c898$$aHuang, Lei$$b0$$eFirst author$$udkfz
000141870 245__ $$aNonsurgical therapies for resected and unresected pancreatic cancer in Europe and USA in 2003-2014: a large international population-based study.
000141870 260__ $$aBognor Regis$$bWiley-Liss$$c2018
000141870 3367_ $$2DRIVER$$aarticle
000141870 3367_ $$2DataCite$$aOutput Types/Journal article
000141870 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1544430661_542
000141870 3367_ $$2BibTeX$$aARTICLE
000141870 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000141870 3367_ $$00$$2EndNote$$aJournal Article
000141870 520__ $$aThe role of chemotherapy in the treatment of pancreatic cancer (PaC) has been well-established, while radiation plays ambiguous roles. This international large-scale population-based study aimed to investigate the real-world application of chemotherapy and radiotherapy for resected and unresected PaC in Europe and USA. Population-based data from multiple European national cancer registries and the US Surveillance, Epidemiology and End Results (SEER)-18 database during 2003-2014 were analyzed. Temporal trends and geographical variations in the application rates of chemotherapy and radiotherapy were quantified using age standardization. Associations of treatment with demographic and clinical characteristics were assessed using multivariable logistic regression. A total of 141,533 PaC patients were analyzed. From 2003-2005 to 2012-2014, chemotherapy administration rates increased in most countries and more strongly among resected patients, while radiation rates were generally low with a slight decline or no obvious trend. In 2012-2014, 12.5% (Estonia) to 61.7% (Belgium) of resected and 17.1% (Slovenia) to 56.9% (Belgium) of unresected patients received chemotherapy. Radiation was administered in 2.6% (Netherlands) to 32.6% (USA) of resected and 1.0% (USA) to 6.0% (Belgium) of unresected patients. Strong temporal and geographical variations were observed. Patterns and strengths of associations of treatment administration with various demographic and clinical factors differed substantially between resected and unresected cancers and varied greatly across countries. Conclusively, administration of chemotherapy but not radiotherapy for PaC increased during the last decade in Europe and USA. Treatment rates were low and the uptake strongly varied across countries, highlighting the need for standardization in PaC treatment to improve patient care.
000141870 536__ $$0G:(DE-HGF)POF3-313$$a313 - Cancer risk factors and prevention (POF3-313)$$cPOF3-313$$fPOF III$$x0
000141870 588__ $$aDataset connected to CrossRef, PubMed,
000141870 7001_ $$0P:(DE-He78)bbfe0ebad1e3b608bca2b49d4f86bd09$$aJansen, Lina$$b1$$udkfz
000141870 7001_ $$00000-0002-4950-0554$$aBalavarca, Yesilda$$b2
000141870 7001_ $$avan der Geest, Lydia$$b3
000141870 7001_ $$aLemmens, Valery$$b4
000141870 7001_ $$aVan Eycken, Liesbet$$b5
000141870 7001_ $$aDe Schutter, Harlinde$$b6
000141870 7001_ $$aJohannesen, Tom B$$b7
000141870 7001_ $$aPrimic-Žakelj, Maja$$b8
000141870 7001_ $$aZadnik, Vesna$$b9
000141870 7001_ $$aMägi, Margit$$b10
000141870 7001_ $$0P:(DE-He78)3772dc9cbbc020fbc52b5f63f1dc1e96$$aPulte, Dianne$$b11$$udkfz
000141870 7001_ $$0P:(DE-He78)01ef71f71b01a3ec3b698653fd43fe86$$aSchrotz-King, Petra$$b12$$udkfz
000141870 7001_ $$0P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aBrenner, Hermann$$b13$$eLast author$$udkfz
000141870 773__ $$0PERI:(DE-600)1474822-8$$a10.1002/ijc.31628$$gVol. 143, no. 12, p. 3227 - 3239$$n12$$p3227 - 3239$$tInternational journal of cancer$$v143$$x0020-7136$$y2018
000141870 909CO $$ooai:inrepo02.dkfz.de:141870$$pVDB
000141870 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)448ff49e51672d79b4747339ac15c898$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000141870 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)bbfe0ebad1e3b608bca2b49d4f86bd09$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000141870 9101_ $$0I:(DE-588b)2036810-0$$60000-0002-4950-0554$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000141870 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)3772dc9cbbc020fbc52b5f63f1dc1e96$$aDeutsches Krebsforschungszentrum$$b11$$kDKFZ
000141870 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)01ef71f71b01a3ec3b698653fd43fe86$$aDeutsches Krebsforschungszentrum$$b12$$kDKFZ
000141870 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aDeutsches Krebsforschungszentrum$$b13$$kDKFZ
000141870 9131_ $$0G:(DE-HGF)POF3-313$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vCancer risk factors and prevention$$x0
000141870 9141_ $$y2018
000141870 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000141870 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000141870 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000141870 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000141870 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bINT J CANCER : 2017
000141870 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000141870 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000141870 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000141870 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000141870 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000141870 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000141870 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bINT J CANCER : 2017
000141870 9201_ $$0I:(DE-He78)C070-20160331$$kC070$$lKlinische Epidemiologie und Alternsforschung$$x0
000141870 9201_ $$0I:(DE-He78)G110-20160331$$kG110$$lPräventive Onkologie$$x1
000141870 980__ $$ajournal
000141870 980__ $$aVDB
000141870 980__ $$aI:(DE-He78)C070-20160331
000141870 980__ $$aI:(DE-He78)G110-20160331
000141870 980__ $$aUNRESTRICTED